Today news
The same in other media
COVID-19: Could a clot-busting drug help save the lives of patients on ventilators?
Reading now: 314
A cycle of blood clotting and inflammation may contribute to the breathing difficulties of some COVID-19 patients. A forthcoming clinical trial will assess whether a type of drug already approved for the prevention of blood clots after a heart attack or stroke might help prevent these difficulties.
Critically ill patients can develop a severe inflammatory lung condition called acute respiratory distress syndrome (ARDS), which affects their ability to breathe unaided.
The hallmark of ARDS is damage to the lining of the lungs from inflammation that allows fluid to build up in the lungs. This inflammation activates increased coagulation within the small vessels of the lungs.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|